M
Mesa Laboratories, Inc.
MLAB · NASDAQ · Healthcare · 593M
Price · close
$124.76
+4.71% · last session
Graham & Buffett's criteria
published figures · last financial year
Price / earningsP/E
102.5×
Price / net assetsP/B
3.7×
Enterprise value / EBITDAEV/EBITDA
23.5×
Free cash flow yieldFCF yield
5.8%
Return on equityROE
3.6%
Operating margin
7.4%
Net debt / EBITDAbalance-sheet strength
4.0×
Interest coverage
1.7×
How we read it
an educational summary · not advice
Figures provided for information and education — they do not constitute personalized investment advice. Investing carries a risk of capital loss.